評論
打印
U.S.
來源于《美國》版塊
ALEXANDRIA OCASIO-CORTEZ TELLS GILEAD CEO THAT 'PEOPLE ARE DYING' BECAUSE HIS COMPANY CHARGES NEARLY $2,000 FOR DRUG THAT SELLS FOR $8 IN AUSTRALIA
亞歷山大•奧卡西奧-科爾特斯告訴吉利德首席執行長，“人們正在死去”，因為他的公司對在澳大利亞售價8美元的藥品收取近2,000美元的費用
BY JASON LEMON
作者：詹森·萊蒙
Representative Alexandria Ocasio-Cortez slammed Gilead CEO Daniel O'Day on Thursday during a congressional hearing, pointing out that his pharmaceutical company charges nearly $2,000 to U.S. customers for Truvada, a drug designed to reduce the risk of HIV, while a generic version of the same drug only costs $8 in Australia.
周四，代表亞歷山大•奧卡西奧-科爾特斯抨擊基列的首席執行官丹尼爾·奧戴在國會聽證會上指出其制藥公司向美國客戶收取近2000美元的特魯瓦達藥費，特魯瓦達是一種旨在降低感染艾滋病毒風險的藥物，而同一種藥物的仿制藥在澳大利亞只需要8美元。
"The current list price (of Truvada) is $2,000 a month in the United States, correct?" the progressive Democratic Congresswoman from New York asked the Gilead CEO on Thursday during a congressional hearing. O'Day clarified that the list price is actually $1,780.
“目前(特魯瓦達)在美國的標價是每月2000美元，對嗎?” 周四，這位來自紐約的進步民主黨國會女議員在國會聽證會上向吉利德首席執行官提問。奧戴澄清說，標價實際上是1780美元。
Ocasio-Cortez shot back: "Why is it $8 in Australia?"
奧卡西奧-科爾特斯反駁道:“為什么在澳大利亞是8美元?”
O'Day explained that Truvada still has patent protection in the U.S. while it does not in the U.S. "It will be generically available in the United States as of September 2020," he said.
奧戴解釋說，特魯瓦達在美國仍然享有專利保護，而在美國則沒有。他說:“到2020年9月，這種疫苗將在美國得到普遍使用。”
The congresswoman then lit into the CEO, arguing that the massive markup would cause people to die. She also explained that Gilead was charging Americans an exorbitant markup for the drug, despite the fact that research for Truvada was paid for by taxpayers and the patent is owned by the public.
隨后，這位國會女議員抨擊了這位首席執行官，稱大幅漲價會導致人們死亡。她還解釋說，盡管特魯瓦達的研究是由納稅人支付的，專利歸公眾所有，但吉利德向美國人收取的藥物加價過高。
譯文由可可原創，僅供學習交流使用，未經許可請勿轉載。
